Smartleaf Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Smartleaf Asset Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-107	Closed	-$1.83K	–	3466
2026 Q1	$1.83K	Buy	107 +47	+78%	+$1.01K	﹤0.01%	2983
2025 Q4	$1.51K	Buy	60 +59	+5,900%	+$1.38K	﹤0.01%	3071
2025 Q3	$22	Buy	+1	New	+$23	﹤0.01%	2993
2024 Q4	–	Sell	-47	Closed	-$1.39K	–	2918
2024 Q3	$1.39K	Sell	47 -9	-16%	-$333	﹤0.01%	2584
2024 Q2	$2.33K	Buy	56 +48	+600%	+$2.17K	﹤0.01%	2173
2024 Q1	$467	Buy	+8	New	+$510	﹤0.01%	1752

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Smartleaf Asset Management's APLS Position: Q2 2026 in Review

Smartleaf Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 107 shares — an estimated $1.83K sold.

Smartleaf Asset Management first reported a position in APLS in Q1 2024 and held it in 6 quarters. The position peaked at $2.33K in Q2 2024. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Smartleaf Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Smartleaf Asset Management sold 107 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.83K.
Smartleaf Asset Management first reported a position in Apellis Pharmaceuticals in Q1 2024 and held it in 6 quarters.
Smartleaf Asset Management's Apellis Pharmaceuticals position peaked at $2.33K in Q2 2024.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.